Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy

The aureolic acid antibiotic mithramycin (MTM) binds selectively to GC-rich DNA sequences and blocks preferentially binding of proteins, like Sp1 transcription factors, to GC-rich elements in gene promoters. Genetic approaches can be applied to alter the MTM biosynthetic pathway in the producing mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Albertini, Veronica, Jain, Aklank, Vignati, Sara, Napoli, Sara, Rinaldi, Andrea, Kwee, Ivo, Nur-e-Alam, Mohammad, Bergant, Julia, Bertoni, Francesco, Carbone, Giuseppina M., Rohr, Jürgen, Catapano, Carlo V.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1420802/
https://www.ncbi.nlm.nih.gov/pubmed/16571899
http://dx.doi.org/10.1093/nar/gkl063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1420802/
https://www.ncbi.nlm.nih.gov/pubmed/16571899
http://dx.doi.org/10.1093/nar/gkl063

Ejemplares similares